MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia
暂无分享,去创建一个
M. Konopleva | R. Klose | O. Heidenreich | Laura J. Godfrey | T. Milne | A. Roy | I. Roberts | E. Repapi | H. Geng | Neil P. Blackledge | Helen Ma | F. Ponthan | J. Kerry | M. Tapia | E. Ballabio | Sorcha O’Byrne